Blood platelets in severely injured burned patients

Unbelievable decrease of blood-platelet in the severely burned patients during the treatment of skingrafting caused two patients to unexpected death. From the records of changes of platelet number, a certain ‘platelet curve’ was made. By observing the curve, our treatments of skingrafting were carried out during the stable period and from then on we had no death cases.     

Antibody-dependent neutrophil-mediated parasite killing in non-lethal rodent malaria

The effects of administrating recombinant human granulocyte colony-stimulating factor (rhG-CSF) and passively transferring immune serum on infection with an attenuated variant of Plasmodium berghei XAT (Pb XAT), in severe combined immunodeficiency (SCID) mice were examined. In immune competent (C.B-17) mice, the attenuated parasite infection was inevitably self-resolving and degenerating forms inside erythrocytes appeared, coinciding with the drop in parasitaemia, whereas SCID mice were unable to control parasite growth and all the mice died. Continuous administration with rhG-CSF caused neutrophilic granulocytosis in both SCID and C.B-17 mice. The effect of rhG-CSF on the infection in C.B-17 mice was to suppress the course of the parasitaemia at an early phase whereas it had no effect in SCID mice. When immune serum was transferred on the day of infection, the prepatent period was prolonged two days in both SCID and C.B-17 mice. When administration with rhG-CSF was combined with transfer of immune serum, SCID mice showed four days delay in patency and degenerating parasites were seen during the course of parasitaemia, although the infection was ultimately fatal. C.B-17 mice similarly treated showed a seven day delay in the onset of the patent parasitaemia which was of a lesser magnitude and shorter in duration compared with control mice. On the other hand, when C.B-17 mice were splenectomized three weeks before infection and then treated with rhG-CSF and immune serum, no degenerating parasites were seen during the infection and all mice died with high parasitaemias. These results show that antibody-dependent neutrophil-mediated parasite killing may occur in the spleen of mice infected with P. berghei XAT.     

131I治疗甲亢性心脏病105例分析

目的 探讨甲亢性心脏病的临床特征、发病相关因素及其治疗方案。方法 对105例甲亢性心脏病患者的临床资料进行回顾性分析。结果 ①甲亢性心脏病患者以中老年女性为主，心律失常以心房纤颤常见；②甲状腺结节性肿大的甲亢患者伴发甲亢性心脏病的几率高于弥漫性肿大的患者；③经^131I抗甲亢治疗以后，随着甲亢的治愈大多数甲亢性心脏病可以治愈。结论 甲亢性心脏病患者的临床特征以心房纤颤、心力衰竭为主，其发病与甲状腺肿大类型有一定的关系，而^131I治疗对甲亢性心脏病的治疗效果非常理想。     

老年急性重症胆管炎的外科治疗(附76例分析)

目的：探讨老年急性重症胆管炎(ACST)的外科治疗。方法：总结60岁以上老年ACST76例，根据病程分段统计手术后并发症率和死亡率。结果：病程在1天以内手术者，并发症率为10．0％，死亡率为0；1～3天手术者，并发症率为21．9％，死亡率为6．3％；3天以上手术者，并发症率为64.3％，死亡率为28．8％。三组之间比较有显著差异(P＜0．01)。结论：老年人ACST治疗上应早期手术，解除胆道梗阻，建立通畅的胆道引流；手术应简捷，尽量缩短手术时间。     

左旋门冬氨酸鸟氨酸在急性重症胆管炎围手术期中的应用研究

目的评估左旋门冬氨酸鸟氨酸在急性重症型胆管炎(ACST)患者围手术期的应用价值。方法将69例ACST患者随机分两组:A组为实验组(应用左旋门冬氨酸鸟氨酸组),共36例;B组为对照组(常规治疗组),共33例。术后第1、5、7天分别检测患者的白细胞计数、血小板计数、ALT、AST、TBIL以及监测肾功能BUN、Cr等指标。结果A组患者上述指标改善明显优于B组,两组数据差异有统计学意义(P<0.05)。结论ACST患者围手术期应用左旋门冬氨酸鸟氨酸可加快患者术后恢复,减少术后并发症及降低病死率。     

Prediction of severe postoperative complications in patients admitted to neuroanaesthesia

The purpose of this study was to identify factors which will predict the risk of severe postoperative complications in individual patients in a neurosurgical unit. Eleven risk factors were investigated in 363 neurosurgical patients, of whom 40 (11%) developed postoperative complications requiring mechanical ventilation for more than 24 h in an intensive care unit, 16 were found to be severely disabled or in a vegetative state at follow-up 1 month after admission, and 28 patients died. By applying stepwise, logistic regression analysis to the patient's data, we were able to select two significant risk variables, i.e. the Glasgow Coma Scale (GCS) 8 or less preoperatively and emergency anaesthesia. The presence of GCS 8 or less on the consciousness scale was associated with postoperative complications in approximately 40% of the cases. Emergency patients with severe neurological damage had the greatest risk of postoperative complications (93%). Fatal outcome for patients with postoperative complications was seen in 40% of the cases.     

心脏病患者血浆心钠素浓度初探

本文报道了采用放射免疫分析法检测的136例健康人和95例心脏病患者血浆心钠素含量的结果。健康人血浆心钠素含量为460．86±23．68ng／L，男女之间，年龄之间无明显差异。心脏病患者的血浆心钠素浓度均高于健康人，心脏病患者心功能越差，血浆心钠素浓度越高，其中以肺心病组变化最为明显。     

应用联合减压术治疗中晚期脑疝疗效观察

目的　观察联合减压术治疗特重型颅脑损伤合并嵌顿性脑疝的效果。方法　将 97例格拉斯哥昏迷评分 (GCS) 3～ 5分的特重型颅脑损伤合并嵌顿性脑疝患者随机分为两组 ,分别采用联合减压术 (46例 )与常规骨瓣开颅术 (5 1例 )治疗 ,术后两组均经常规治疗。随访 1～ 32个月 ,平均 7个月。比较两组患者临床疗效、颅内压变化及并发症发生率。结果　联合减压治疗组有效率为 80 .4 % (37/ 4 6例 ) ,其中恢复良好、中残2 7例 (占 5 8.7% ) ,重残 10例 (占 2 1.7% ) ,死亡 9例 (占 19.6 % ) ;常规骨瓣开颅术对照组有效率为 33.4 %(17/ 5 1例 ) ,其中恢复良好、中残 6例 (占 11.8% ) ,重残 11例 (占 2 1.6 % ) ,死亡 34例 (占 6 6 .6 % ) ,两组有效率和病死率比较差异均有显著性 (P均 <0 .0 1)。联合减压治疗组患者颅内压下降速度和程度优于常规骨瓣开颅术对照组 (P<0 .0 5 )。联合减压治疗组患者的急性脑膨出、切口疝、切口脑脊液漏、外伤性癫疒间及术后枕叶脑梗死发生率均明显低于常规骨瓣开颅术对照组 (P<0 .0 5或 P<0 .0 1) ,但两组术后颅内感染发生率差异无显著性 (P>0 .0 5 )。结论　联合减压术治疗特重脑损伤合并嵌顿性脑疝患者的疗效优于常规骨瓣开颅术。     

SARS相关冠状病毒S1融合蛋白的原核表达与纯化

目的：克隆严重急性呼吸综合征相关冠状病毒(SARS-CoV)S1蛋白编码DNA，构建原核表达质粒pGEX-5T／S1，并诱导表达谷胱甘肽巯基转移酶融合蛋白。方法：采用PCR方法扩增合成S1片段，并克隆入载体中，经双酶切鉴定和测序后把S1序列定向插入原核表达载体pGEX-5T的多克隆位点，转化大肠杆菌K802，将纯化后的融合蛋白用于SARS—CoV抗体阳性血清的检测。结果：GST—S1融合蛋白以可溶形式表达，纯化后的蛋白用ELISA法检测，结果与对照相符。结论：成功诱导原核表达并纬化出融合蛋白S1，为将其应用于SARS—CoV的特异性检测和亚单位疫苗研究奠定了基础。     

治疗老年重症呼吸衰竭42例临床分析

目的：探讨机械通气联合支气管肺泡灌洗（BAL）在治疗老年重症呼吸衰竭的作用。方法：选择常规治疗后病情无缓解的重症老年呼吸衰竭患者42例。建立人工气道行钡械通气治疗12～24h后，低氧血症纠正不理想，气道压力偏高，痰多者，应用加温至37℃生理盐水加庆大霉素、地塞米松及爱全乐经纤支镜行BAL，吸除呼吸道粘稠分泌物，每日一次，连续3—5天。结果：42例患者中，37例通气24h，经支气管肺泡灌洗后，气道压力下降，临床症状好转，缺氧及二氧化碳滞留得到改善，病原菌得到明确，成功脱机出院。结论：对老年重症呼吸衰竭在机械通气的基础上联合支气管肺泡灌洗是治疗呼吸衰竭安全有效的重要措施，值得临床应用。